Global Human Growth Hormone (hGH) Market Analysis and Forecasts 2014-2017 & 2025: Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, SGA - ResearchAndMarkets.com

DUBLIN--()--The "Human Growth Hormone (hGH) Market Analysis By Application (Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, SGA), By Region, And Segment Forecasts, 2014 - 2025" report has been added to ResearchAndMarkets.com's offering.

The global human growth hormone (hGH) market is expected to reach USD 7.1 billion by 2025

Rising cases of pituitary dysfunction and increasing use of human growth hormone are likely to drive the market in coming years.

Turner syndrome, growth hormone deficiency, Prader-Willi syndrome, idiopathic short stature, and small for gestational age (SGA) are major disorders in which growth hormone (GH) are used. Additionally, growth hormone also received an approval for other indications such as Creutzfeldt-Jakob disease, chronic kidney disease, SHOX gene haploinsufficiency, and Noonan syndrome.

Although FDA has not approved the use of hGH as anti-aging therapy, many practitioners offer injections of growth hormones at higher prices. The hGH therapy is aggressively promoted for advanced age symptoms.

hGH is anabolic as it accelerates protein synthesis and breaks down fat. Hence, athletes involved in strength demanding activities and sports are likely to use growth hormones for its anabolic effects. It is a fairly common practice among athletes and body-builders to use combination of anabolic steroids and GH for the benefits.

Some of the key players are Pfizer, Inc.; Merck & Co., Inc.; Eli Lilly and Company, Genentech, Inc., Novo Nordisk, Sandoz International GmbH, Ferring Holding SA, and Ipsen.

Key Topics Covered:

Chapter 1 Executive Summary

Chapter 2 Research Methodology

Chapter 3 Human Growth Hormone Market Variables, Trends & Scope

Chapter 4 Human Growth Hormone Market: Application Estimates & Trend Analysis

Chapter 5 Human Growth Hormone Market: Regional Estimates & Trend Analysis

Chapter 6 Competitive Landscape

  • Novo Nordisk
  • Pfizer
  • Eli Lilly
  • Sandoz International GmbH
  • Merck
  • Genentech
  • Ferring Pharmaceuticals
  • Ipsen

For more information about this report visit https://www.researchandmarkets.com/research/tr7l9t/global_human?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Endocrine and Metabolic Disorders Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Endocrine and Metabolic Disorders Drugs